News

AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) peptide has garnered attention for its intriguing biological properties ...
Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...
Why do problems occur with a special variant of 'protein glues', the split inteins, that severely limit their use in producing proteins? A team has now answered this question.
To overcome these limitations, we engineered oncolytic viruses co-expressing neoantigens and neoantigen-binding major histocompatibility complex (MHC) molecules to force ectopic delivery of ...
State Key Laboratory of Applied Organic Chemistry, College of Chemistry and Chemical Engineering, Lanzhou University, Lanzhou 730000, Gansu, China ...
The researchers, whose study is published in Pharmacological Research, identified the smallest part of a peptide (small protein ... powerful regulators for the synthesis of signalling molecules ...
Current therapies fail to attenuate such complications. Here, we identify formyl-peptide receptor type 2 (FPR2) as a therapeutic target to treat heart and lung dysfunction associated with inflammatory ...
Russia Scientific and Educational Laboratory of Chemical and Pharmaceutical Research, Siberian State Medical University, Tomsk 634050, Russia Research Centrum for Oncotheranostics, Research School of ...
HIGH THROUGHPUT: PE Applied Biosystems’ ABI 394 DNA/RNA Synthesizer is controlled by a Macintosh computer. Polypeptides (proteins) and polynucleotides (DNA/RNA) are the two essentials of organic life.